首页 › 基金 › 5AM Venture Management, LLC › TRDA

5AM Venture Management, LLC 对 TRDA 的持仓历史

ENTRADA THERAPEUTICS INC · 医疗保健

5AM Venture Management, LLC 在 Q3 2026 的 13F 申报中披露持有 TRDA(ENTRADA THERAPEUTICS INC)3,784,650 股,市值约 US$24.0M,约占其申报组合的 8.09%,在其申报持仓中市值排名第 2 位。 5AM Venture Management, LLC 最近 13 个申报季度中有 13 个季度披露了 TRDA 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)3.78M 股
申报持仓市值$24.03M
组合权重8.09%
首次申报Q3 2023
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

5AM Venture Management, LLC 对 TRDA 的持仓演变

5AM Venture Management, LLC 于 Q3 2023 首次披露 TRDA 持仓:4,408,379 股(约 US$69.7M)。 该持仓在 Q4 2024 达到峰值 4,408,379 股,市值约 US$76.2M。 在 13 次申报中,5AM Venture Management, LLC 0 次增持、4 次减持、8 次保持不变。 最近一期申报(Q3 2026)显示持股 3,784,650 股、市值约 US$24.0M,环比减持 -271,729 股。。

逐季持仓明细

季度股数金额变化
Q3 2023 4.41M $69.65M 新进
Q4 2023 4.41M $66.52M 持有
Q1 2024 4.41M $62.47M 持有
Q2 2024 4.41M $62.82M 持有
Q3 2024 4.41M $70.45M 持有
Q4 2024 4.41M $76.22M 持有
Q1 2025 4.41M $39.85M 持有
Q2 2025 4.31M $28.95M 减持
Q3 2025 4.26M $24.69M 减持
Q4 2025 4.06M $41.70M 减持
Q1 2026 4.06M $51.19M 持有
Q2 2026 4.06M $29.85M 持有
Q3 2026 3.78M $24.03M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 TRDA 与 13F 数据

TRDA(ENTRADA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 TRDA,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$32.2M), Merck & Co., Inc. (US$11.0M), Trails Edge Capital Partners, LP (US$9.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TRDA 的基金

查看 TRDA 的全部基金持有人 →

常见问题

How long has 5AM Venture Management, LLC held TRDA?

5AM Venture Management, LLC has disclosed TRDA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is 5AM Venture Management, LLC's current position in TRDA?

As of Q3 2026, 5AM Venture Management, LLC holds 3.78M shares of TRDA (ENTRADA THERAPEUTICS INC), valued at $24.03M, representing 8.09% of its reported portfolio and ranking #2.

Has 5AM Venture Management, LLC been buying or selling TRDA?

In the latest 13F filing (Q3 2026), 5AM Venture Management, LLC reduced its position in TRDA. The position peaked in Q4 2024 at 4.41M shares.

Which other funds hold TRDA?

Other major institutional holders of TRDA include BAKER BROS. ADVISORS LP, Merck & Co., Inc., Trails Edge Capital Partners, LP, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.